Improving Peptides
Small firms develop better peptide drug candidates to expand this pharmaceutical class and attract big pharma partners
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
May 30, 2011 Cover
Volume 89, Issue 22
Small firms develop better peptide drug candidates to expand this pharmaceutical class and attract big pharma partners
Credit:
Small firms develop better peptide drug candidates to expand this pharmaceutical class and attract big pharma partners
More than 30 years after his death, a selection of R. B. Woodward’s notes on conducting materials is published
Recent failure of UN talks raises concerns over likelihood of success of efforts to create a green economy
Historical analysis of inflated yield and purity data in organic synthesis papers points to pressure to produce high-impact results
As Europe moves toward a ban on some phthalates, producers of the plasticizers look to diversify
Scientists use various ways to strengthen immune response to carbohydrate cancer antigens